Extract notice to the Minister
Aimovig (migraine)
Common name / Subject : érénumab
Name of the manufacturer : Novartis
Form : Sol. Inj. S.C. (stylo)
Dosage : 70 mg/ml (1ml), 140 mg/ml (1ml)
Name of the manufacturer : Novartis
Form : Sol. Inj. S.C. (stylo)
Dosage : 70 mg/ml (1ml), 140 mg/ml (1ml)
Indication : Prévention de la migraine chez l'adulte
INESSS' Recommendation
Refus d'inscription
Minister's decisions
Surseoir à la décision (2019-12-18)
Evaluation published on December 11, 2019